ELTX logo

Elicio Therapeutics, Inc.

ELTX
0.00
USD
+0.00+0.00%

Elicio Therapeutics, Inc. at a glance

Open ELTX on Vela

Elicio Therapeutics, Inc. (ELTX) is a Healthcare company in the Biotechnology industry, headquartered in Boston, MA, with about 33 employees. Its shares trade on NASDAQ, and its IPO date is February 5, 2021. With a market capitalization of $36.2 million, ELTX is a small-cap stock.

It trades an average of 1.3 million shares a day.

In its latest reported quarter (results released August 13, 2026), Elicio Therapeutics, Inc. posted earnings of -$0.43 per share, against an estimate of -$0.54.

Figures as of October 24, 2026, from market data providers. Descriptive only, not financial advice.

ELTX: Frequently asked questions

As of October 24, 2026, Elicio Therapeutics, Inc. has a market capitalization of $36.2 million, making it a small-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.